Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM) [Phase 2]
Phase 2 trial LaSAR BeaM evaluating Laser Interstitial Thermal Therapy or surgical resection with adjuvant reirradiation for recurrent brain…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases [Phase 1]
A Phase 1 study of trastuzumab deruxtecan in combination with stereotactic radiosurgery for HER2-positive breast cancer with brain metastase…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
This clinical trial is testing a new MRI technique to visualize changes in brain metastases after treatment. The study is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases [EARLY_Phase 1]
A Phase 0/1 study of GSK5764227, a B7-H3-targeted antibody-drug conjugate, in patients with recurrent grade 4 glioma (including glioblastoma…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery for patients with more than three melanoma brain metastases; the study is currently activ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis [Phase 2]
A Phase 2 study is evaluating stereotactic radiosurgery for brain metastases from small cell lung cancer. The trial is currently active but …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
This clinical trial update notes ongoing recruitment for a study at MD Anderson evaluating patient perceptions of quality of care delivered …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Brain Imaging Biomarkers in Patients With Brain Metastasis [Phase 2]
Phase 2 clinical trial update focusing on brain imaging biomarkers in patients with brain metastases. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: FLT-PET / MRI Brain Mets
Clinical trial update for FLT-PET / MRI imaging in patients with brain metastases and radionecrosis, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases [NA]
ClinicalTrials.gov update describes a study comparing neoadjuvant versus adjuvant stereotactic radiotherapy for brain metastases; the trial …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases [NA]
A clinical trial evaluating preoperative radiosurgery versus postoperative stereotactic radiotherapy for resectable brain metastases, curren…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating azeliragon in combination with stereotactic radiation therapy for brain metastases and is currently…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer
This ClinicalTrials.gov update shows a study evaluating local treatments for brain metastases arising from gastric and esophageal cancer, sp…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. [Phase 3]
Phase 3 clinical trial evaluating adding anlotinib to whole-brain radiotherapy in small cell lung cancer patients with brain metastases; cur…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis [Phase 1, Phase 2]
An ongoing phase 1/phase 2 trial assessing the safety and efficacy of NEO212 in patients with diffuse astrocytoma (IDH-mutant), glioblastoma…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System [Phase 2]
Phase 2 clinical trial evaluating gadolinium-based contrast agents with ferumoxytol-enhanced MRI to diagnose abnormalities in the central ne…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 trial is evaluating a Fluorine-18 labeled AlphaVbeta6-binding peptide as a PET imaging agent for metastatic non-small cell lung…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases [Phase 3]
Phase 3 clinical trial comparing bevacizumab to corticosteroids as first-line treatment for symptomatic cerebral radiation necrosis after ra…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis [Phase 2]
Phase 2 trial update for repotrectinib in ROS1-positive non-small cell lung cancer patients with active brain metastases; currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab deruxtecan for brain cancer, including glioblastoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]
Phase 4 trial evaluating 64Cu-DOTA-Trastuzumab PET/MRI for imaging HER2-positive breast cancer with brain metastases; currently recruiting a…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases [Phase 3]
Phase 3 trial comparing stereotactic radiosurgery to observation for patients with brain metastases is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors [EARLY_Phase 1]
An early Phase 1 trial evaluates MeFAMP as an imaging agent for amino acid transport in brain tumors. The study targets recurrent glioma and…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Development of MRF for Characterization of Brain Tumors After Radiotherapy [NA]
Development of a Magnetic Resonance Framework (MRF) to characterize brain tumors after radiotherapy, with recruitment ongoing at Case Compre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning [NA]
This clinical trial investigates motor-eloquent navigated transcranial magnetic stimulation to assist radiosurgery planning for patients wit…